Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 31

1.

Incomplete silencing of full mutation alleles in males with fragile X syndrome is associated with autistic features.

Baker EK, Arpone M, Aliaga SM, Bretherton L, Kraan CM, Bui M, Slater HR, Ling L, Francis D, Hunter MF, Elliott J, Rogers C, Field M, Cohen J, Cornish K, Santa Maria L, Faundes V, Curotto B, Morales P, Trigo C, Salas I, Alliende AM, Amor DJ, Godler DE.

Mol Autism. 2019 May 3;10:21. doi: 10.1186/s13229-019-0271-7. eCollection 2019.

2.

Clinical and Molecular Differences between 4-Year-Old Monozygous Male Twins Mosaic for Normal, Premutation and Fragile X Full Mutation Alleles.

Pandelache A, Baker EK, Aliaga SM, Arpone M, Forbes R, Stark Z, Francis D, Godler DE.

Genes (Basel). 2019 Apr 5;10(4). pii: E279. doi: 10.3390/genes10040279.

3.

Assessing a Hyperarousal Hypothesis of Insomnia in Adults with Autism Spectrum Disorder.

Baker EK, Richdale AL, Hazi A, Prendergast LA.

Autism Res. 2019 Mar 21. doi: 10.1002/aur.2094. [Epub ahead of print]

PMID:
30896090
4.

Exploring autism symptoms in an Australian cohort of patients with Prader-Willi and Angelman syndromes.

Baker EK, Godler DE, Bui M, Hickerton C, Rogers C, Field M, Amor DJ, Bretherton L.

J Neurodev Disord. 2018 Aug 6;10(1):24. doi: 10.1186/s11689-018-9242-0.

5.

Intragenic DNA methylation in buccal epithelial cells and intellectual functioning in a paediatric cohort of males with fragile X.

Arpone M, Baker EK, Bretherton L, Bui M, Li X, Whitaker S, Dissanayake C, Cohen J, Hickerton C, Rogers C, Field M, Elliott J, Aliaga SM, Ling L, Francis D, Hearps SJC, Hunter MF, Amor DJ, Godler DE.

Sci Rep. 2018 Feb 26;8(1):3644. doi: 10.1038/s41598-018-21990-x.

6.

Employment status is related to sleep problems in adults with autism spectrum disorder and no comorbid intellectual impairment.

Baker EK, Richdale AL, Hazi A.

Autism. 2019 Feb;23(2):531-536. doi: 10.1177/1362361317745857. Epub 2018 Feb 18.

PMID:
29455555
7.

Assessing the Dim Light Melatonin Onset in Adults with Autism Spectrum Disorder and No Comorbid Intellectual Disability.

Baker EK, Richdale AL, Hazi A, Prendergast LA.

J Autism Dev Disord. 2017 Jul;47(7):2120-2137. doi: 10.1007/s10803-017-3122-4.

PMID:
28444476
8.

Examining the Behavioural Sleep-Wake Rhythm in Adults with Autism Spectrum Disorder and No Comorbid Intellectual Disability.

Baker EK, Richdale AL.

J Autism Dev Disord. 2017 Apr;47(4):1207-1222. doi: 10.1007/s10803-017-3042-3.

PMID:
28160224
9.

Young Children with ASD Use Lexical and Referential Information During On-line Sentence Processing.

Bavin EL, Kidd E, Prendergast LA, Baker EK.

Front Psychol. 2016 Feb 19;7:171. doi: 10.3389/fpsyg.2016.00171. eCollection 2016.

10.

Ciliary neurotrophic factor has intrinsic and extrinsic roles in regulating B cell differentiation and bone structure.

Askmyr M, White KE, Jovic T, King HA, Quach JM, Maluenda AC, Baker EK, Smeets MF, Walkley CR, Purton LE.

Sci Rep. 2015 Oct 21;5:15529. doi: 10.1038/srep15529.

11.

Sleep Patterns in Adults with a Diagnosis of High-Functioning Autism Spectrum Disorder.

Baker EK, Richdale AL.

Sleep. 2015 Nov 1;38(11):1765-74. doi: 10.5665/sleep.5160.

12.

The Adult Repetitive Behaviours Questionnaire-2 (RBQ-2A): A Self-Report Measure of Restricted and Repetitive Behaviours.

Barrett SL, Uljarević M, Baker EK, Richdale AL, Jones CR, Leekam SR.

J Autism Dev Disord. 2015 Nov;45(11):3680-92. doi: 10.1007/s10803-015-2514-6.

13.

BET inhibitors induce apoptosis through a MYC independent mechanism and synergise with CDK inhibitors to kill osteosarcoma cells.

Baker EK, Taylor S, Gupte A, Sharp PP, Walia M, Walsh NC, Zannettino AC, Chalk AM, Burns CJ, Walkley CR.

Sci Rep. 2015 May 6;5:10120. doi: 10.1038/srep10120.

14.

Systematic Screening Identifies Dual PI3K and mTOR Inhibition as a Conserved Therapeutic Vulnerability in Osteosarcoma.

Gupte A, Baker EK, Wan SS, Stewart E, Loh A, Shelat AA, Gould CM, Chalk AM, Taylor S, Lackovic K, Karlström Å, Mutsaers AJ, Desai J, Madhamshettiwar PB, Zannettino AC, Burns C, Huang DC, Dyer MA, Simpson KJ, Walkley CR.

Clin Cancer Res. 2015 Jul 15;21(14):3216-29. doi: 10.1158/1078-0432.CCR-14-3026. Epub 2015 Apr 10.

15.

Wnt inhibitory factor 1 (WIF1) is a marker of osteoblastic differentiation stage and is not silenced by DNA methylation in osteosarcoma.

Baker EK, Taylor S, Gupte A, Chalk AM, Bhattacharya S, Green AC, Martin TJ, Strbenac D, Robinson MD, Purton LE, Walkley CR.

Bone. 2015 Apr;73:223-32. doi: 10.1016/j.bone.2014.12.063. Epub 2015 Jan 5.

PMID:
25571841
16.

Myelosuppressive therapies significantly increase pro-inflammatory cytokines and directly cause bone loss.

Quach JM, Askmyr M, Jovic T, Baker EK, Walsh NC, Harrison SJ, Neeson P, Ritchie D, Ebeling PR, Purton LE.

J Bone Miner Res. 2015 May;30(5):886-97. doi: 10.1002/jbmr.2415.

17.

Methylation of the SLC6a2 gene promoter in major depression and panic disorder.

Bayles R, Baker EK, Jowett JB, Barton D, Esler M, El-Osta A, Lambert G.

PLoS One. 2013 Dec 2;8(12):e83223. doi: 10.1371/journal.pone.0083223. eCollection 2013.

18.

Modeling distinct osteosarcoma subtypes in vivo using Cre:lox and lineage-restricted transgenic shRNA.

Mutsaers AJ, Ng AJ, Baker EK, Russell MR, Chalk AM, Wall M, Liddicoat BJ, Ho PW, Slavin JL, Goradia A, Martin TJ, Purton LE, Dickins RA, Walkley CR.

Bone. 2013 Jul;55(1):166-78. doi: 10.1016/j.bone.2013.02.016. Epub 2013 Feb 26.

PMID:
23486187
19.

EphrinB2/EphB4 inhibition in the osteoblast lineage modifies the anabolic response to parathyroid hormone.

Takyar FM, Tonna S, Ho PW, Crimeen-Irwin B, Baker EK, Martin TJ, Sims NA.

J Bone Miner Res. 2013 Apr;28(4):912-25. doi: 10.1002/jbmr.1820.

20.

Genetically engineered mouse models and human osteosarcoma.

Ng AJ, Mutsaers AJ, Baker EK, Walkley CR.

Clin Sarcoma Res. 2012 Oct 4;2(1):19. doi: 10.1186/2045-3329-2-19.

Supplemental Content

Loading ...
Support Center